Miguel Gonzalez Velez, Medical Oncologist at John Theurer Cancer Center, Hackensack University Medical Center, shared a post on LinkedIn:
“Anyone in the US regularly uses CEA as indirect response marker or ctDNA beat nonspecific markers.
Study from Latin America congrats to the authors Oscar Arrieta and Claudio Martin.”
Title: Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer
Authors: Oscar Arrieta, Edgar Varela-Santoyo, Andrés Cardona, Roberto Sánchez-Reyes, Luis Lara-Mejía, Suraj Bassarmal, Dafne Valle-Bautista, Luis Corrales-Rodríguez, Daniel Motola-Kuba, Luis Cabrera-Miranda, Claudio Martín
Read the Full Article.
Other articles about NSCLC on OncoDaily.